These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29442298)

  • 21. Discounting in cost-utility analysis of healthcare interventions: reassessing current practice.
    Cohen BJ
    Pharmacoeconomics; 2003; 21(2):75-87. PubMed ID: 12515570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonthermal Endovenous Procedures for Varicose Veins: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(8):1-188. PubMed ID: 34211617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of federal funding cuts on family planning services, 1980-1983.
    Torres A
    Fam Plann Perspect; 1984; 16(3):134-8. PubMed ID: 6381091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does a One-Size-Fits-All Cost-Sharing Approach Incentivize Appropriate Medication Use? A Roundtable on the Fairness and Ethics Associated with Variable Cost Sharing.
    Graff JS; Shih C; Barker T; Dieguez G; Larson C; Sherman H; Dubois RW
    J Manag Care Spec Pharm; 2017 Jun; 23(6):621-627. PubMed ID: 28530519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Financial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey data.
    McLeod L; Bereza BG; Shim M; Grootendorst P
    Open Med; 2011; 5(1):e1-9. PubMed ID: 22046212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health versus other sectors: Multisectoral resource allocation preferences in Mukono district, Uganda.
    Yemeke TT; Kiracho EE; Mutebi A; Apolot RR; Ssebagereka A; Evans DR; Ozawa S
    PLoS One; 2020; 15(7):e0235250. PubMed ID: 32730256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(7):1-165. PubMed ID: 34211616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fall and rise of cost sharing in Kenya: the impact of phased implementation.
    Collins D; Quick JD; Musau SN; Kraushaar K; Hussein IM
    Health Policy Plan; 1996 Mar; 11(1):52-63. PubMed ID: 10155878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
    Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
    Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Internet-Delivered Cognitive Behavioural Therapy for Post-traumatic Stress Disorder or Acute Stress Disorder: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(9):1-120. PubMed ID: 34527087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personalized commissioning, public spaces: the limits of the market in English social care services.
    Needham C
    BMC Health Serv Res; 2013; 13 Suppl 1(Suppl 1):S5. PubMed ID: 23735124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups.
    Beswick AD; Rees K; Griebsch I; Taylor FC; Burke M; West RR; Victory J; Brown J; Taylor RS; Ebrahim S
    Health Technol Assess; 2004 Oct; 8(41):iii-iv, ix-x, 1-152. PubMed ID: 15461879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(10):1-234. PubMed ID: 32284770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Effectiveness and Budget Impact of Lumacaftor/Ivacaftor in the Treatment of Cystic Fibrosis.
    Vadagam P; Kamal KM; Covvey JR; Giannetti V; Mukherjee K
    J Manag Care Spec Pharm; 2018 Oct; 24(10):987-997. PubMed ID: 30247102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of health leadership and management capacity in the Solomon Islands.
    Asante A; Roberts G; Hall J
    Pac Health Dialog; 2012 Apr; 18(1):166-77. PubMed ID: 23240354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How important is severity for the evaluation of health services: new evidence using the relative social willingness to pay instrument.
    Richardson J; Iezzi A; Maxwell A
    Eur J Health Econ; 2017 Jul; 18(6):671-683. PubMed ID: 27456337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the budget impact of new technologies added to the National List of Health Services in Israel: stakeholders' incentives for adopting a financial risk-sharing mechanism.
    Hammerman A; Greenberg D
    Health Policy; 2009 Jan; 89(1):78-83. PubMed ID: 18579253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health technology assessment (HTA) and economic evaluation: efficiency or fairness first.
    Richardson J; Schlander M
    J Mark Access Health Policy; 2019; 7(1):1557981. PubMed ID: 30651941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Societal Preferences for Funding Orphan Drugs in the United Kingdom: An Application of Person Trade-Off and Discrete Choice Experiment Methods.
    Bourke SM; Plumpton CO; Hughes DA
    Value Health; 2018 May; 21(5):538-546. PubMed ID: 29753350
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.